
KGC · NYSE
Consensus is Buy across 14 analysts, with a mean price target of $38. The supplied data provides no low or high targets, so target clustering and the width of the target spread cannot be measured. No named analyst or firm is identified as most or least bullish, and no rating or target revisions are supplied for the past week. The evidence-based disagreement is therefore operational rather than attributable to specific analysts: higher gold prices and Q2’s earnings beat support the bullish view, while lower production, rising costs, U.S. cost pressure and project-execution requirements support a more cautious interpretation. Kinross’s decision to hold 2026 guidance is the key point separating those views.